NIPPON INDIA PHARMA FUND vs HDFC Pharma and Healthcare Fund

Portfolio Overlap Analysis · HDFC vs Nippon

41.7%
High Overlap
13 common stocks · Rank #2308 of 28,292 pairs
Fund A
NIPPON INDIA PHARMA FUND
Nippon · Sectoral - Pharma
Fund B
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma

Common Holdings (10)

StockWt% in NIPPON INDIA PHARMAWt% in HDFC Pharma and HealthcareOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
13.08%9.81%9.81%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
6.56%8.38%6.56%
Lupin Limited
Pharmaceuticals & Biotechnology
7.99%6.44%6.44%
Max Healthcare Institute Limited
Healthcare Services
3.49%6.36%3.49%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
2.51%4.80%2.51%
Vijaya Diagnostic Centre Limited
Healthcare Services
3.49%2.30%2.30%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
2.20%6.21%2.20%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
3.07%2.09%2.09%
Dr. Lal Path Labs Limited
Healthcare Services
2.05%1.63%1.63%
Thyrocare Technologies Limited
Healthcare Services
2.08%1.39%1.39%

Unique to NIPPON INDIA PHARMA

  • Dr. Reddy's Laboratories Limited5.81%
  • Cipla Limited5.67%
  • Apollo Hospitals Enterprise Limited5.17%
  • MedPlus Health Services Limited3.70%
  • Ajanta Pharma Limited3.41%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%
  • Fortis Healthcare Limited4.02%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
31.6% (8)
Healthcare Services
10.1% (5)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for NIPPON INDIA PHARMA

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.